Fukui, Kimiko
Wirkus, Johannes M.
Hartmann, Erik K.
Schmidtmann, Irene
Pestel, Gunther J.
Griemert, Eva-Verena http://orcid.org/0000-0002-9959-3189
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 31 October 2022
Accepted: 9 February 2023
First Online: 27 February 2023
Declarations
:
: Approval was granted by the State ethics committee of Rhineland-Palatinate, Germany (authorization number 837.004.16). Written informed consent was obtained from all patients enrolled in the study. We conducted the study in accordance with the declaration of Helsinki 1996 and ICH guideline E6 (Good Clinical Practice) and registered the protocol prior to enrolment of the first patient on clinicaltrials.gov (NC T03280953; PI Kimiko Fukui, M.D., Ph.D.).
: Not applicable.
: Gunther Pestel received an unrestricted educational grant from Nihon Kohden Europe GmbH, Rosbach, Germany.Kimiko Fukui was involved in lectures on esophageal doppler monitoring organized by Deltex Medical Ltd, Chichester, UK.Johannes M. Wirkus has no financial or non-financial interests to disclose.Erik K. Hartmann has no financial or non-financial interests to disclose.Irene Schmidtmann has no financial or non-financial interests to disclose.Eva-Verena Griemert has no financial or non-financial interests to disclose.